๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Navi Mumbai
Clinical trial register · India

Clinical Trials in Navi Mumbai

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
Mumbai 32 Navi Mumbai 11 Delhi 2 Muzaffarpur 1 Bhubaneswar 1
Narrow the registerReset
Recruitment status
Phase
Site location
Mumbai32 Navi Mumbai11 Delhi2 Muzaffarpur1 Bhubaneswar1
All 12 locations
Target enrolment
to
11 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
NCT07719946Haploidentical Hematopoietic Stem Cell Transplant, Hematological Malignancies
Tata Memorial Centre
Phase 2
20
Navi Mumbai
2025-03-26
Recruiting
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
NCT07724873Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease, Hematological Malignancy
Tata Memorial Centre
Phase 1/2
54
Navi Mumbai
2025-01-28
Recruiting
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
NCT07709195Oral Mucositis, Total Body Irradiation, Hematological Malignancies, Hematopoietic Stem Cell Transplantation (HSCT)
Tata Memorial Centre
Phase 2
17
Navi Mumbai
2024-10-30
Recruiting
Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
NCT07709013Hematologic Malignancies
Tata Memorial Centre
Phase 2
22
Navi Mumbai
2024-10-18
Recruiting
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia
NCT06058572Acute Leukemia
Tata Memorial Centre
Phase 2
166
Navi Mumbai
2024-08-02
Recruiting
Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.
NCT07708987Hematological Malignancy, GVHD - Graft-Versus-Host Disease, Steriod Refractory
Tata Memorial Centre
Phase 2
34
Navi Mumbai
2023-09-23
Recruiting
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
NCT07021677T Acute Lymphoblastic Leukemia
Tata Memorial Centre
Phase 2
18
Navi Mumbai
2023-08-28
Recruiting
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
NCT05857631Cervical Cancer, Endometrial Cancer
Tata Memorial Centre
Not applicable
90
Navi Mumbai, Mumbai
2023-05-29
Recruiting
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
NCT05142982Seminoma
Tata Memorial Centre
Not applicable
74
Mumbai, Navi Mumbai
2021-12-01
Active, closed
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
NCT03561961Prostate Adenocarcinoma
Tata Memorial Centre
Not applicable
526
Navi Mumbai
2018-05-24
Active, closed
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer
NCT02302105Prostate Cancer
Tata Memorial Centre
Not applicable
224
Navi Mumbai
2011-11-25
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/navi-mumbai

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.